Emerging Infectious Disease ISSN: 1080-6059

Characterization of Flagella Produced by Clinical Strains of Stenotrophomonas maltophilia

Doroti de Oliveira-Garcia*†, Monique Dall'Agnol‡, Mónica Rosales‡, Ana C.G.S. Azzuz§, Marina B. Martinez†§, and Jorge A. Girón‡

Author affiliations: *Laboratório Clínico do Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil; †Departamento de Microbiologia do Instituto de Ciências Biomédicas da Universidade de São Paulo, São Paulo, Brazil; ‡Benemerita Universidad Autónoma de Puebla, Puebla, México; §Departamento de Análises Clínicas da Faculdade de Ciências Farmacêuticas da Universidade de São Paulo, São Paulo, Brazil;

Main Article

Figure 4

Reactivity of Stenotrophomonas maltophilia flagellin with different antibodies. Lane 1, SMDP92 strain; lane 2, ATCC 13637. Blots containing whole cells extracts of SMDP92 and ATCC 13637 were reacted with antibodies against SMFliC, flagella of Proteus mirabilis, and anti-FlaA and anti-FlaB of Pseudomonas aeruginosa.

Figure 4. Reactivity of Stenotrophomonas maltophilia flagellin with different antibodies. Lane 1, SMDP92 strain; lane 2, ATCC 13637. Blots containing whole cells extracts of SMDP92 and ATCC 13637 were reacted with antibodies against SM_FliC, flagella of Proteus mirabilis, and anti-FlaA and anti-FlaB of Pseudomonas aeruginosa.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.